10X Fund, L.P.
SEC Form 4 insider trading activity
10X Fund, L.P. has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Dec 18, 2025.
On the most recent filing, 10X Fund, L.P. is listed as 10% Owner at GALECTIN THERAPEUTICS INC. Inside the rolling window, 10X Fund, L.P. reported no open-market purchases and 5 open-market sales totaling $2.3M in GALT. The largest disclosed transaction in the window is a sale of 252,069 GALT shares on Dec 3, 2025, worth $1.4M.
Companies traded
Other insiders at GALT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has 10X Fund, L.P. made?
10X Fund, L.P. has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does 10X Fund, L.P. trade?
10X Fund, L.P. has filed SEC Form 4 disclosures for 1 company, including GALT.
When was 10X Fund, L.P.'s most recent SEC Form 4 filing?
10X Fund, L.P.'s most recent SEC Form 4 filing on Tracefour is dated Dec 18, 2025.
What is 10X Fund, L.P.'s total buy and sell value in the current window?
Inside the rolling retention window, 10X Fund, L.P. bought $0 and sold $2.3M based on SEC Form 4 filings.
What was 10X Fund, L.P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 252,069 GALT shares on 2025-12-03, worth $1.4M, per SEC Form 4 filings.